Company / Cash per Share
Inhibrx Biosciences, Inc. Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$8.58
FY2025
5-year range
$3.22 / $23.59
FY2023-FY2025
Trend
+166.4%
vs FY2024
Sector context
#24 of 205
Health Care
What the data says
Inhibrx Biosciences, Inc.'s cash per share of $8.58 is higher than 88% of companies in the Health Care sector (FY2025). Declined from $23.59 to $8.58 over the past 2 years.
Based on SEC 10-K filings.
8.58 in FY2025. Top quartile in the Health Care sector.
Declined from $23.59 to $8.58 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 205This company $8.58 Sector average $72.93
▼
-88.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 166.4% year-over-year.
- Ranks #24 out of 205 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.58 | +166.4% |
| FY2024 | $3.22 | -86.3% |
| FY2023 | $23.59 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026